相关实验视频

Updated: May 22, 2025

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection

Published on: November 7, 2018

病毒复制活动与与HBV相关的肝细胞癌的术后复发之间的关联

Subin Heo¹, Jiwon Yang², Jeayeon Park³

¹Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.

Alimentary pharmacology & therapeutics

|March 17, 2025

概括

基线B型肝炎病毒 (HBV) 复制活性影响切除后肝细胞癌 (HCC) 复发风险. 抗病毒治疗 (AVT) 的时间非常重要,特别是在肝硬化患者中,影响结果和监测策略.

科学领域:

肝病学肝病学是一种肝病学.
病毒瘤学病毒瘤学
临床医学临床医学

背景情况:

基线病毒复制活性是慢性乙型肝炎病毒 (HBV) 感染中肝细胞癌 (HCC) 发展的已知危险因素.
了解影响HCC治疗后复发的因素对于患者管理至关重要.

研究的目的:

为了研究基线HBV复制活性对治疗切除后HCC复发的影响.
为了比较正在接受持续抗病毒治疗 (AVT) 的患者与在切除时启动AVT的患者之间的复发风险.

主要方法:

对2384名患有早期HBV相关HCC,接受治疗切除和AVT (2010-2018) 的多国回顾性队列的分析.
患者被分为"正在进行的AVT"和"开始的AVT"组.
基于基线病毒复制活性和患者肝硬化状态来评估HCC复发情况.

主要成果:

在正在进行的AVT和启动AVT组之间,整体复发风险类似 (HR 1.09).
在肝硬化患者中,启动AVT显示出更高的复发风险 (HR 1.22),与非肝硬化患者不同 (HR 0.90).
开始AVT的非肝硬化患者的基线HBVDNA为5-6 log10 IU/mL,其复发风险明显更高 (HR 1.78).

结论:

在HBV复制活动和HCC复发之间的关系随着肝硬化状态而变化.
优化AVT启动时间和量身定制手术后监测对于管理与HBV相关的HCC至关重要.
这些发现为HCC患者的个性化治疗策略提供了关键的见解.

关键词:

这就是HBV的DNA.克隆扩张的扩张.这是一种炎症炎症炎症炎症.肝癌是一种肝癌.核子是同类的同类物质.

更多相关视频

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

相关概念视频

Mechanisms of Retrovirus-induced Cancers

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

Viral Recombination

Viral Recombination

Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.

Viral Mutations

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...